The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2022
Filed:
May. 08, 2019
Lg Chem, Ltd., Seoul, KR;
Young Kwan Kim, Daejeon, KR;
Ohhwan Kwon, Daejeon, KR;
Heedong Park, Daejeon, KR;
Junggyu Park, Daejeon, KR;
Hwan Geun Choi, Seoul, KR;
Jung Beom Son, Incheon, KR;
Eunhwa Ko, Daegu, KR;
So Young Kim, Daegu, KR;
Seungyeon Lee, Daegu, KR;
Seock Yong Kang, Seoul, KR;
Yi Kyung Ko, Daegu, KR;
Jin-Hee Park, Mokpo-si, KR;
LG CHEM, LTD., Seoul, KR;
Abstract
The present invention relates to a novel compound exhibiting enteropeptidase-inhibiting activity, a pharmaceutically acceptable salt thereof, a pharmaceutical composition for preventing and treating metabolic diseases such as obesity, diabetes mellitus or hyperlipidemia, etc. comprising the compound or pharmaceutically acceptable salt, and a method for preventing or treating metabolic disease using the above novel compound. The compound of the present invention has excellent inhibitory activity against enteropeptidase, and thus is not absorbed into the body, but are excreted outside the body. However, since not only fat but also protein are discharged together, it has few side effects such as fat stools and acts only in the gastrointestinal tract, so it has few side effects such as depression, and is very useful as a therapeutic or prophylactic drug for various metabolic diseases such as obesity, diabetes mellitus, and hyperlipidemia.